Loading provider…
Loading provider…
Cardiovascular Disease Physician in Los Angeles, CA
NPI: 1184646358Primary Practice Location
RONALD REAGAN UCLA MEDICAL CENTER
757 Westwood Plz, Los Angeles, CA
Primary Employer
UCLA Medical Plaza
uclahealth.org
HQ Phone
Get MD Karol's Phone Numberphone_androidMobile
Get MD Karol's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1991 - 2026
CA State Medical License

American Board of Internal Medicine
Cardiovascular Disease
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Cardiovascular Disease
1992 - 1998
Residency • Internal Medicine
1990 - 1992
Harvard Medical School
hms.harvard.edu
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 1,058 | 1,432 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 191 | 279 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 33 | 33 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 29 | 30 |
Bone morphogenetic protein expression in human atherosclerotic lesions.
Authors: Kristina Bostrom
Journal: J Clin Invest
Authors: Robert Barr, Elizabeth Oelsner, Joseph Schwartz
Journal: Ann Am Thorac Soc
Authors: Olcay Aksoy, Rajan Saggar, Gregg Fonarow, Boback Ziaeian, Marcella Press, John Moriarty, Eric Yang, Manyoo Agarwal, Richard Channick
Journal: Chest
Publication Date: 2022-08-02
Lead Sponsor: Karol E. Watson, MD
Collaborators: University of California, Los Angeles
Intervention / Treatment: DEVICE: 7-Day Continuous Glucose Monitoring with Abbott Freestyle Libre 2
Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators: National Institute on Aging (NIA), American Diabetes Association, National Institute on Minority Health and Health Disparities (NIMHD), National Cancer Institute (NCI), US Department of Veterans Affairs, National Heart, Lung, and Blood Institute (NHLBI), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Eye Institute (NEI), National Center for Research Resources (NCRR), Office of Research on Women's Health (ORWH), Centers for Disease Control and Prevention, Indian Health Service (IHS), General Clinical Research Program
Intervention / Treatment: DRUG: Metformin, BEHAVIORAL: Intensive Lifestyle Group Session, BEHAVIORAL: DPPOS Group Lifestyle, BEHAVIORAL: DPPOS Boost Lifestyle
Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)